Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses

This publication has 52 references indexed in Scilit:

• Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk
  Transplantation and Cellular Therapy, 2002
• Preterminal host dendritic cells in irradiated mice prime CD8+ T cell–mediated acute graft-versus-host disease
  Journal of Clinical Investigation, 2002
• TNF-α antagonists for the treatment of Crohn’s disease
  Expert Opinion on Pharmacotherapy, 2000
• Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells
  Hematological Oncology, 1999
• The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy
  Annual Review of Medicine, 1999
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
  The Journal of Experimental Medicine, 1998
• The Graft-Versus-Leukemia Effect of Post-transplant Donor Leukocyte Infusion
  Leukemia & Lymphoma, 1996
• Anti-TNF-alpha and Pentoxifylline for Prophylaxis of aGvHD in Murine Allogeneic Bone Marrow Transplantation
  Oncology Research and Treatment, 1992
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987
• Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells
  Nature, 1985